Valuation: MELA Sciences Inc

Market Cap 588 534.2 493.57 445.83 841.35 55.21K 870.95 5.94K 2.35K 29.63K 2.21K 2.16K 93.85K P/E 2024
-1.1x
P/E 2025 -0.94x
Enterprise Value 8.36M 7.59M 7.01M 6.34M 11.96M 785M 12.38M 84.36M 33.42M 421M 31.36M 30.69M 1.33B EV / Sales 2024
0.64x
EV / Sales 2025 0.51x
Free-Float
71.75%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer - 11/07/2026
Chief Operating Officer - 13/11/2023
Comptroller/Controller/Auditor 51 12/11/2024
Director TitleAgeSince
Chairman 58 02/07/2023
Director/Board Member 87 28/05/2018
Director/Board Member 62 26/03/2024
Change 5-day change 1-year change 3-year change Capi.($)
-1.27%-4.20%+19.46%+46.32% 256B
-1.33%-2.22%+3.93%+9.95% 162B
-1.32%-4.95%-20.34%+44.02% 152B
-1.47%-0.75%-57.45%-20.08% 63.33B
-0.04%+2.29%+24.11%+58.75% 61.59B
-0.41%+1.95%+0.30%-10.99% 53.86B
-0.60%-4.02%+17.78%+51.43% 48.75B
-0.75%-2.32%+2.02%+70.70% 48.46B
-1.48%-4.88%+19.51%+70.33% 44.56B
Average -0.95%-0.29%+1.04%+35.60% 99B
Weighted average by Cap. -1.10%-0.31%+2.51%+34.80%

Financials

2024 2025
Net sales 33.56M 30.49M 28.17M 25.45M 48.02M 3.15B 49.71M 339M 134M 1.69B 126M 123M 5.36B 30.7M 27.89M 25.77M 23.27M 43.92M 2.88B 45.47M 310M 123M 1.55B 115M 113M 4.9B
Net income -10.09M -9.16M -8.47M -7.65M -14.43M -947M -14.94M -102M -40.34M -508M -37.85M -37.05M -1.61B -6.26M -5.69M -5.26M -4.75M -8.96M -588M -9.27M -63.2M -25.04M -315M -23.49M -23M -999M
Net Debt 9.18M 8.34M 7.7M 6.96M 13.13M 862M 13.59M 92.65M 36.71M 462M 34.44M 33.71M 1.46B 8.36M 7.59M 7.01M 6.34M 11.96M 785M 12.38M 84.35M 33.42M 421M 31.36M 30.69M 1.33B
Logo MELA Sciences Inc
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.
Employees
-